Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer

NCT02800889 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study withdrawn; no participants enrolled

Conditions

Lymphoma
Solid Tumor (Excluding CNS)

Interventions

DRUG: Pixantrone

Sponsor

CTI BioPharma